E. Vámos

发表

Effects of valproate on the dopaminergic system in mice

P. Klivényi, L. Vécsei, A. Csáti, 2009, Neurological research.

The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection

P. Klivényi, J. Toldi, Á. Párdutz, 2009, Journal of the Neurological Sciences.

Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

P. Klivényi, J. Toldi, L. Vécsei, 2009, Journal of Neural Transmission.

Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat.

J. Toldi, Á. Párdutz, J. Tajti, 2015, CNS & neurological disorders drug targets.

Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus.

J. Toldi, Á. Párdutz, J. Tajti, 2009, European journal of pharmacology.

Kynurenate Derivative Attenuates the Nitroglycerin‐Induced CamKIIα and CGRP Expression Changes

J. Toldi, Á. Párdutz, J. Tajti, 2009, Headache.

Selective inhibition of cyclooxygenase-2 attenuates nitroglycerin-induced calmodulin-dependent protein kinase II alpha in rat trigeminal nucleus caudalis

Á. Párdutz, J. Tajti, L. Vécsei, 2009, Neuroscience Letters.

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease

P. Klivényi, L. Vécsei, D. Zádori, 2009, Pharmacology Biochemistry and Behavior.

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.

P. Klivényi, L. Vécsei, E. Vámos, 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives.

J. Toldi, F. Fülöp, I. Szatmári, 2009, Current medicinal chemistry.

Protective compounds in animal models of trigeminal activation and neurodegeneration.

E. Vámos, 2012, Ideggyogyaszati szemle.

Neuroprotective effects of probenecid in a transgenic animal model of Huntington’s disease

P. Klivényi, L. Vécsei, D. Zádori, 2009, Journal of Neural Transmission.

Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex

G. Veres, J. Toldi, Á. Párdutz, 2014, Journal of Neural Transmission.

Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives

J. Toldi, L. Vécsei, F. Fülöp, 2010 .

l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus

J. Toldi, Á. Párdutz, J. Tajti, 2009, Neuropharmacology.

Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat

J. Schoenen, Á. Párdutz, L. Vécsei, 2012, Experimental Neurology.

Migraine is a neuronal disease

J. Toldi, Á. Párdutz, J. Tajti, 2011, Journal of Neural Transmission.

Digital PCR to determine the number of transcripts from single neurons after patch-clamp recording.

László G Puskás, Sándor Lovas, Márton Rózsa, 2013, BioTechniques.

Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat

J. Schoenen, Á. Párdutz, L. Vécsei, 2012, Experimental Neurology.

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease

P. Klivényi, L. Vécsei, D. Zádori, 2009, Pharmacology Biochemistry and Behavior.

Cox‐2 Inhibitor Attenuates NO‐Induced nNOS in Rat Caudal Trigeminal Nucleus

Á. Párdutz, J. Tajti, L. Vécsei, 2007, Headache.

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.

P. Klivényi, L. Vécsei, E. Vámos, 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.